One Nucleus is a membership organisation for international life science and healthcare companies. We are based in Cambridge and London UK, the heart of Europe’s largest life science and healthcare cluster.
|Telephone:||+44 (0)1223 896 450|
|Address:||The Portway, Granta Park, Little Abington|
|Membership type:||Corporate 6-20 (£250+VAT pa)|
Established in 1997, and formerly known as ERBI, One Nucleus is a not-for-profit, membership organisation owned by its members and located in Cambridge and London – the centre of Europe’s leading life science and healthcare cluster.
More than 500 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.
One Nucleus’s mission is to maximise the global competitiveness of our members. For our science and technology-based members, that means being global leaders in the research, development and commercialisation of healthcare innovations that radically improve the quality of people’s lives around the world. For our business and professional services members, it means delivering exceptional services that significantly enhance the business performance of their clients.
London and Cambridge
One Nucleus was formed in April 2010 by the merger of two regional lifescience networks – Cambridge-based ERBI and the London Biotechnology Network (LBN). Together we form a commercial, clinical and academic powerhouse. London and Cambridge are home to at least 60% of the UK’s life science industry base, four of the UK’s five Academic Health Science Centres and three of the world’s top six universities. The merger of ERBI and LBN recognises that the Cambridge-London network is an international life science “super cluster”.
The merger, driven by requests from ERBI and LBN members, results in several member benefits including:
- A large pool of companies to support business-to-business interaction
- Membership of a cluster of international size, relevance and visibility
- One membership providing discounted entry to events in London and Cambridge
- Economies of scale supporting our group purchasing scheme
- An expanded training programme focused on the needs of members
One Nucleus recognises that a company’s employees are its most valuable asset. Many rapidly growing companies overlook the need for ongoing training of their staff.
One Nucleus, the Cambridge based not-for-profit membership organisation for the London-East of England life sciences and healthcare cluster, is delighted to announce the appointment of Derek Jones as a Non-Executive Director. Derek is Chief Executive of Babraham Bioscience Technologies Ltd (BBT), the organisation responsible for the development and management of the Babraham Research Campus.
8 March 2018Read in full
Neurodegenerative diseases are incurable conditions in which nerve cells gradually degenerate, or die, for reasons that are not yet understood. Neurodegenerative diseases include Alzheimer’s, Parkinson's, Huntington's, Motor Neurone disease, Creutzfeldt-Jakob and Multiple Sclerosis, many of which give rise to dementia.
27 February 2018Read in full
One Nucleus, the not-for-profit membership organisation for international life science and healthcare companies, is delighted to announce that Tony Jones, currently Director of Business Development at One Nucleus, is to become the company’s new Chief Executive.
18 July 2017Read in full
One Nucleus, the Cambridge based not-for-profit membership organisation for international life science and healthcare companies, is delighted to announce the appointment of Linda Summerton as a Director. Linda is Chief Executive of Immodulon and a Senior Partner with TranScrip Partners.
13 February 2017Read in full
PharmaVentures has become the latest Partner to join forces with One Nucleus. Both PharmaVentures and One Nucleus are committed to playing an active and supportive role in assisting in the success of the life sciences sector nationally and internationally.
14 January 2015Read in full
Four leading life science membership organisations, the BioIndustry Association (BIA), Bionow, BioPartner and One Nucleus (ON) announce the formation of United Life Sciences, a strategic partnership representing over 1000 life science and healthcare members across the UK and internationally. The aim of the partnership is to work together on a range of matters that directly benefit members and the wider UK sector.
9 October 2014Read in full
It is excellent news for One Nucleus members and the wider life sciences sector to hear that the Government is committing more financial assistance than ever before to assist eligible UK organisations who wish to join international trade missions to biotech events this autumn.
21 August 2013Read in full
There has never been a time when the phrase ‘Cash is King’ has played more heavily on the minds of life science company executives.
5 August 2013Read in full
24 Apr 2019The Anchor Pub Silver Street Cambridge, Cambridgeshire CB3 9EL
Fancy a catch up with the network in a relaxed and informal setting?
Approaches and tools to consider to maximise success on the therapeutic protein journey from research product to clinic
2 May 2019Cambridge Building Babraham Research Campus Cambridge, Cambridgeshire CB22 3AT
One Nucleus and Lonza Biologics are pleased to invite you to join them for a complimentary symposium on Thursday 2 May at The Babraham Research Campus, Cambridge to gain insight from experts in the different approaches and techniques to successfully progress therapeutic proteins from discovery to the clinic.
3 Jun 2019The Portway Granta Park Great Abington Cambridge, Cambridgeshire CB21 6GS
This one-day intensive course is all about health and safety in the laboratory setting.
11 Jun 2019The Portway Granta Park Great Abington Cambridge, Cambridgeshire CB21 6GS
By taking this training programme, you will be able to address projects in small-to-medium biotech, pharma, academic and service businesses, which are generally more challenging than rolling out a simple plan.
11 Jun 2019The Francis Crick Institute, 1 Midland Road, London NW1 1ST
In collaboration with Eli Lilly and The Francis Crick Institute
19 Jun 2019Royal Veterinary College 4 Royal College Street London, London NW1 0TU
For those involved in biomedical research, whether Academia, venture backed biotech SME, technical service provider or large Pharma the impact arising from their research spend is always a factor of the quality of the staff they can employ.
27 Jun 2019One Nucleus Limited The Portway Granta Park Cambridge, Cambridgeshire CB21 6GS
Those wanting to gain a comprehensive picture of the science and processes underpinning today’s drug discovery.
9 Jul 2019 - 10 Jul 2019The Cambridge Building, Babraham Research Campus, Babraham CB22 3AT
ON Helix is One Nucleus' translational research conference for the Life Sciences industry.
11 Dec 2019QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE
Building on the evolution of the past 18 years, Genesis 2019 will assemble senior executives and decision makers from across the Life Science, Healthcare and Technology field to present, discuss and demonstrate their collective insight and thought leadership for the sector, themselves and their stakeholders.